secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2022-11-17T23:59:59+00:00
Accession:  0001193125-22-287687
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya Therapeutics prices public offering of ~28.85M shares/warrants for ~$75M gross proceeds
--------------------------------------------------------------------------------

- Priced public offering of 22,613,307 common shares at $2.60 and 6,236,693 pre-funded warrants at $2.599 per warrant.
- Gross proceeds expected ~$75M before expenses; underwriters have 30-day option for up to 4,327,500 additional shares.
- Offering expected to close Nov 21, 2022; joint book-runners: Morgan Stanley and Piper Sandler.
- Pre-funded warrants have exercise price of $0.001 per share; all securities sold by the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000119312522287687/0001193125-22-287687-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000119312522287687/d383621d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-287687

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer